Ascomp with Codeine
- Product NDC
- 79739-6094
- 11-digit product format
- 797396094
- Labeler code
- 79739
- Product ID
- 79739-6094_e8714e9d-80cc-4c5e-b469-67ce10256d85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Butalbital, Aspirin, Cafeine, and Codeine Phosphate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- LGM PHARMA SOLUTIONS, LLC
- Application
- ANDA075231
- Marketing category
- ANDA
- Marketing start
- 2001-11-30
- Substance
- ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
- Active strength
- 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 79739-6094 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… | ||
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 79739-6094 | 79739-6094-1 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075231-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A075231-001 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE / ORAL | AB | 2001-11-30 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A075231-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A075231-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075231-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075231-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075231-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075231-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075231-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075231-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075231-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075231-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A075231-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075231-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075231-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075231-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A075231-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075231-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A075231-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A075231-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A075231-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A075231-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A075231-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075231-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A075231-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A075231-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A075231-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A075231-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A075231-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A075231-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075231-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A075231-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A075231-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075231-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075231-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075231-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075231-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A075231-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A075231-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075231-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A075231-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A075231-001 | AB | 1 | e64feba35796… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ascomp with Codeine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUTALBITAL | 325 mg/1 |
| ASPIRIN | 50 mg/1 |
| CAFFEINE | 40 mg/1 |
| CODEINE PHOSPHATE | 30 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| KHS0AZ4JVK | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
| GSL05Y1MN6 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1cab3106-1064-4b42-892b-39f405d9e02f | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79739-6094-1 | Ascomp with Codeine | 100 in 1 BOTTLE | CAPSULE | 100 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 79739-6094 | ASCOMP WITH CODEINE (BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE) CAPSULE [LGM PHARMA SOLUTIONS, LLC] | 13 | Current NDC, Legacy NDC, 1 package rows | 20241018_1cab3106-1064-4b42-892b-39f405d9e02f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Bryant Ranch Prepack | 95a33c9b-79a6-47c7-8433-fc217950b88f | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 075231 ANDA075231 |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Breckenridge Pharmaceutical, Inc. | 243a6aea-0f48-42a9-a85e-ff247ab94336 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 075231 ANDA075231 |
| Ascomp with Codeine | BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE | LGM PHARMA SOLUTIONS, LLC | 1cab3106-1064-4b42-892b-39f405d9e02f | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | 075231 ANDA075231 79739-6094 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 994239 | Ascomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule | PSN | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994237 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule | PSN | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994239 | aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp] | SBD | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994237 | aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule | SCD | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994237 | ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule | SY | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994239 | ASA 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Ascomp] | SY | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
| 994239 | Ascomp with Codeine (ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule | SY | 1cab3106-1064-4b42-892b-39f405d9e02f | 15 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 79739-6094-1 | 79739609401 | 100 CAPSULE in 1 BOTTLE (79739-6094-1) | 100 capsule | 2020-07-24 | 0000-00-00 | No | No | Current |